Molecular Imaging News and Research

RSS

Scientists showcase HDL nanotherapy that may provide solution to repeat heart attacks

Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries - the process that leads to clots rupturing and causing myocardial infarction or stroke.

22 Jan 2014

New technology may provide solution to high risk of repeat heart attacks, say scientists

Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke.

20 Jan 2014

Three new spin-offs emerged from Helmholtz Zentrum München

Three new spin-offs emerged from Helmholtz Zentrum München (HMGU) in 2013: SurgVision, Trianta Immunotherapies and Dosimetrics. Thanks to successful innovation management, the Center has transformed excellent research findings into practical applications and given new impulses to the areas of clinical imaging, immunotherapy and radiation dosimetry.

17 Jan 2014

MRI method to map creatine in heart may help detect disorders earlier than traditional methods

A new MRI method to map creatine at higher resolutions in the heart may help clinicians and scientists find abnormalities and disorders earlier than traditional diagnostic methods, researchers at the Perelman School of Medicine at the University of Pennsylvania suggest in a new study published online today in Nature Medicine.

13 Jan 2014

PET imaging of brain reveals ketamine may act as antidepressant by regulating serotonin activity

Ketamine is a potent anesthetic employed in human and veterinary medicine, and sometimes used illegally as a recreational drug. The drug is also a promising candidate for the fast treatment of depression in patients who do not respond to other medications.

7 Jan 2014

Researchers discover biological mechanism that allows brain tumor cells to escape from drugs

Researchers from UCLA's Jonsson Comprehensive Cancer Center have discovered a biological mechanism that allows brain tumor cells to escape from the drugs designed to target them, resulting in drug resistance. The study was published in the December 5, 2013 online issue of Science.

6 Dec 2013

Study reveals that brain cancer cells resist therapy by dialing down gene mutation targeted by drugs

A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped.

6 Dec 2013

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.

4 Dec 2013

Seed grants support cancer diagnosis and treatment, vascular health research

Five teams of scientists earned research seed grants awarded this year by the John S. Dunn Foundation. The awards support new collaborations by researchers at Rice University's BioScience Research Collaborative (BRC) and their partners at other institutional members of the Gulf Coast Consortia (GCC).

26 Nov 2013

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Zevacor Molecular, an independently owned healthcare firm that manufactures and distributes PET and SPECT radiopharmaceuticals, has purchased the first 70 MeV Cyclotron dedicated to medical use in the United States from Ion Beam Applications, S.A.

5 Nov 2013

SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

MILabs is pleased to announce that Sunnybrook Research Institute, the research arm of the Sunnybrook Health Sciences Centre, located in Toronto, Canada will install a MILabs VECTor+ system to expand their current preclinical molecular imaging capabilities.

4 Nov 2013

U of T researchers develop method to screen human stem cells

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.

23 Oct 2013

Thomson Reuters, Orion Bionetworks partner to further understanding of multiple sclerosis

The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced a collaboration with Orion Bionetworks to further the understanding of multiple sclerosis and advance the development of new therapies by generating predictive models of patient stratification and drug targets.

22 Oct 2013

New $1.9M research grant to support investigators to detect tumors in earliest stages of formation

The National Cancer Institute's new Provocative Questions research funding program has awarded a prestigious grant to researchers at the Case Comprehensive Cancer Center and Case Western Reserve University's Schools of Medicine and Engineering to study tumor detection at the earliest stages of growth.

16 Oct 2013

Understanding genetic, physiological basis for metabolic diseases related to circadian function

A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.

24 Sep 2013

World’s first preclinical Magnetic Particle Imaging (MPI) system announced by Bruker

At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today announced the world’s first Magnetic Particle Imaging (MPI) system, an entirely new technology for preclinical imaging. The addition of MPI as a complementary preclinical imaging technique for disease studies, translational research and drug discovery, has significant potential in helping researchers gain new insights into disease processes at the organ, cellular and molecular level.

From Bruker BioSpin Division 19 Sep 2013

Multimodal animal bed introduced by Bruker

Today, at the 2013 World Molecular Imaging Congress (WMIC), Bruker introduces a new multimodal animal bed enabling multiple sequential imaging sessions in preclinical research with robust repositioning between scans, while avoiding unwanted motion of the animal during the investigation. This optimizes results for image fusion, combined processing and evaluation of preclinical research applications requiring multiple imaging modalities across multiple systems.

From Bruker BioSpin Division 19 Sep 2013

ParaVision® 6 software from Bruker introduced at 2013 World Molecular Imaging Congress

At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today introduces its ParaVision® 6 software, setting new standards in preclinical MRI software that delivers significantly enhanced productivity for both, routine users and accomplished experts. A redefined workflow introduces optimized, application-oriented experimental protocols, an intuitive, interactive 3D scan planning viewport, and automatic reporting. Thanks to its DICOM-based data exchange module, ParaVision 6 seamlessly integrates with data from multimodal imaging studies employed in many preclinical research labs.

From Bruker BioSpin Division 19 Sep 2013

Researchers develop brown fat detection method to combat obesity

When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.

19 Sep 2013

UAB Comprehensive Cancer Center celebrates grand opening of Wallace Tumor Institute

On Friday, Aug. 23, the University of Alabama at Birmingham Comprehensive Cancer Center celebrated the public grand opening of the renovated Lurleen B. Wallace Tumor Institute (WTI).

18 Sep 2013

Molecular Imaging News and Research

Scientists showcase HDL nanotherapy that may provide solution to repeat heart attacks

New technology may provide solution to high risk of repeat heart attacks, say scientists

Three new spin-offs emerged from Helmholtz Zentrum München

MRI method to map creatine in heart may help detect disorders earlier than traditional methods

PET imaging of brain reveals ketamine may act as antidepressant by regulating serotonin activity

Researchers discover biological mechanism that allows brain tumor cells to escape from drugs

Study reveals that brain cancer cells resist therapy by dialing down gene mutation targeted by drugs

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

Seed grants support cancer diagnosis and treatment, vascular health research

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

U of T researchers develop method to screen human stem cells

Thomson Reuters, Orion Bionetworks partner to further understanding of multiple sclerosis

New $1.9M research grant to support investigators to detect tumors in earliest stages of formation

Understanding genetic, physiological basis for metabolic diseases related to circadian function

World’s first preclinical Magnetic Particle Imaging (MPI) system announced by Bruker

Multimodal animal bed introduced by Bruker

ParaVision® 6 software from Bruker introduced at 2013 World Molecular Imaging Congress

Researchers develop brown fat detection method to combat obesity

UAB Comprehensive Cancer Center celebrates grand opening of Wallace Tumor Institute

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News